Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial Officer Conference Call Participants Ed Arce - H.C. Wainwright Joseph Schwartz - SVB Securities Ken Cacciatore - Cowen & Company Justin Kim - Oppenheimer & Company Sahil Dhingra - RBC Capital Markets David Martin - Bloom Burton Maury Raycroft - Jefferies Operator Greetings, and welcome to Aurinia Pharma ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants DeDe Sheel – Vice President-Investor Relations Peter Greenleaf – President and Chief Executive Officer Joe Miller – Chief Financial Officer Neil Solomons – Chief Medical Officer Conference Call Participants Ed Arce – HC Wainwright Justin Kim – Oppenheimer Olivia Brayer – Cantor Fitzgerald Sahil Dhingra – RBC Operator Greetings, and welcome to Aurinia Pharmaceuticals Second Quarter 2022 ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Dana Lynch - Director of Corporate Communications & Corporate Affairs Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial Officer Max Colao - Chief Commercial Officer Neil Solomons - Chief Medical Officer Conference Call Participants Olivia Brayer - Cantor Fitzgerald Maury Raycroft - Jeffries Stacy Ku - Cowen and Company Ed Arce - HC Wainwright Sahil Dhingra ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2021 Earnings Conference Call February 28, 2022 8:30 AM ET Company Participants Dana Lynch - Director of Corporate Communications & Corporate Affairs Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Maury Raycroft - Jefferies Joseph Schwartz - SVB Securities Stacy Ku - Cowen and Company Ed Arce - H.C. Wainwright David Martin - Bloom Burton Operator Greetings, ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2021 Earnings Conference Call November 3, 2021 8:30 AM ET Company Participants Dana Lynch – Investor Relations and Corporate Communications Peter Greenleaf – President and Chief Executive Officer Joe Miller – Chief Financial Officer Max Colao – Chief Commercial Officer Neil Solomons – Chief Medical Officer Conference Call Participants Alethia Young – Cantor Fitzgerald Ed Arce – H.C. Wainwright and Company Farzin Haque – Jefferies Ken Cacciatore – Cowen and Compa ...